CD274 and neoplasm: In the CTRL-group, there was a 19.3% higher proportion of patients with a positive PD-L1 status and a 20.1% higher proportion with a PD-L1 ≥50% tumor proportion score (TPS) compared to the COMB group, and these differences were statistically significant.